NASDAQ:AVXL   Anavex Life Sciences Corp.
FDA just approved stage 2 of clinical trial and technical analysis looks really good.

Here are some targets for some really nice returns
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。